H2020
OptiMalVax
Optimizing a deployable high efficacy malaria vaccine
- Programme
- Horizon 2020
- Started
- Ends
- Duration
- 72 months
- Total cost
- EUR 23,741,229
- EU contribution
- EUR 20,050,441
- Participants
- 18 from 8 countries
- Topic
- H2020_SC1-PM-06-2016
- Grant agreement
- 733273
Coordinated by The Chancellor, Masters and Scholars of the University of Oxford (GBUnited Kingdom).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| The Chancellor, Masters and Scholars of the University of Oxford | GBUnited Kingdom | Coordinator | EUR 12,064,496 | PIC (1.00) |
| James Cook University | AUAustralia | Participant | EUR 0 | PIC (1.00) |
| Universite de Lausanne | CHSwitzerland | Participant | EUR 0 | known name (0.95) |
| Vaccine Formulation Institute(ch)ltd | CHSwitzerland | Participant | EUR 0 | PIC (1.00) |
| EXPRES2ION Biotechnologies Aps | DKDenmark | Participant | EUR 445,056 | PIC (1.00) |
| Statens Serum Institut | DKDenmark | Participant | EUR 1,965,000 | known name (0.95) |
| Imaxio SA | FRFrance | Participant | EUR 5,158 | PIC (1.00) |
| Institut de Recherche Pour le Developpement | FRFrance | Participant | EUR 183,775 | known name (0.95) |
| Osivax Sas | FRFrance | Participant | EUR 19,842 | PIC (1.00) |
| Sorbonne Universite | FRFrance | Participant | EUR 437,500 | known name (0.95) |
| London School of Hygiene and Tropical Medicine Royal Charter | GBUnited Kingdom | Participant | EUR 25,000 | PIC (1.00) |
| United Kingdom Research and Innovation | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| Academisch Ziekenhuis Leiden | NLNetherlands | Participant | EUR 1,179,726 | PIC (1.00) |
| Janssen Vaccines & Prevention BV | NLNetherlands | Participant | EUR 25,000 | PIC (1.00) |
| Stichting Radboud Universitair Medisch Centrum | NLNetherlands | Participant | EUR 3,274,888 | PIC (1.00) |
| Stichting Radboud Universiteit | NLNetherlands | Participant | EUR 0 | known name (0.95) |
| Novavax AB | SESweden | Participant | EUR 150,000 | PIC (1.00) |
| Program for Appropriate Technologyin Health | USUnited States | Participant | EUR 25,000 | PIC (1.00) |
Changes of the consortium
First seen on with 18 participants from 8 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.